Otha Myles
Internal Medicine · Overland, MONPI 1649379546
Payments from drug & device makers
What this record shows
The money is spread across several categories — speaking fees (49.8%), consulting fees and travel and lodging — rather than concentrated in one kind of arrangement. 21 manufacturers reported payments, led by Gilead at 51.8% of the total. Reporting peaked in 2019 at $37,459 and has fallen 84.5% since, to $5,821 in 2022. Among internal medicine clinicians in MO with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 168 payments — averaging $363.47 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Gilead$32K
- Pfizer$18K
- Viiv Healthcare Company$11K
- Johnson & Johnson$234
- AstraZeneca$144
- Janssen Products, LP$100
- plus $577 from 15 others
What the payments were for
- Consulting fees$17,77529%
- Speaking & faculty fees$30,42750%
- Travel & lodging$10,33317%
- Food & beverage$2,4154%
- Education$1130%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Gilead | 56 | $31,626 |
| Pfizer | 25 | $17,777 |
| Viiv Healthcare Company | 33 | $10,606 |
| Johnson & Johnson | 17 | $234 |
| AstraZeneca | 3 | $144 |
| Janssen Products, LP | 1 | $100 |
| Merck | 6 | $83 |
| GSK | 5 | $69 |
| Janssen Scientific Affairs, LLC | 2 | $65 |
| Astellas Pharma US Inc | 3 | $61 |
| AbbVie(2 entities) | 4 | $56 |
| Mylan Institutional Inc. | 2 | $44 |
| Napo Pharmaceuticals Inc | 1 | $37 |
| Tetraphase Pharmaceuticals, Inc. | 2 | $35 |
| Novo Nordisk | 2 | $28 |
| Lilly USA, LLC | 1 | $20 |
| EMD Serono, Inc. | 1 | $20 |
| Amarin Pharma, Inc. | 1 | $16 |
| Otsuka America Pharmaceutical, Inc. | 1 | $15 |
| E.r. Squibb & Sons, L.L.C. | 1 | $15 |
| Cumberland Pharmaceuticals, Inc. | 1 | $12 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Descovy$17,280
- PREVNAR - 13$14,248
- Truvada$10,951
- DOVATO$6,555
- Veklury$1,610
- PREVNAR 20$1,312
- Biktarvy$420
- FARXIGA$119
How this compares
$61,063 in reported general payments places this provider in the 95th percentile of 2,097 internal medicine providers in Missouri.
Other internal medicine in Overland
- Timothy SmithSaint Peters$428K
- Craig DietzKansas City$226K
- Kevin SuttmoellerKansas City$198K
- Vinay KamatSaint Louis$191K
- David PrelutskySaint Louis$182K
- Dima DandachiColumbia$157K
- Justin SteinkampSaint Charles$139K
- Tracy NorfleetSaint Louis$132K
- Paul OlivoSaint Louis$98K
- William SummersSaint Louis$93K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.